News

Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study
As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...
CDC weighing end to universal COVID vaccine recommendations
Less than a quarter of adults and around 13% of children have gotten a COVID-19 vaccination this past season, CDC data shows, ...
The Herald Journal20h
SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA
Preliminary data showed Novavax's non-mRNA JN.1 COVID-19 vaccine induced lower frequency and severity of short-term side ...
Yale study links persistent spike protein to post Covid-19 vaccination syndrome and immune dysregulation
Chiropractic physician Dr. Cathleen Gerenger joined Gayle Guyardo, host of the global health and wellness show Bloom, to discuss long COVID symptoms and the findings of a ...
Novavax’s COVID-19 vaccine shows lower side effects vs. Pfizer-BioNTech’s
Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...
Key vaccine committee meets for the first time under Robert F. Kennedy Jr.
A key vaccine advisory committee is meeting for the first time under new U.S. Health Secretary Robert F. Kennedy Jr., a ...
CNN on MSN13d
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
FOX 24 Charleston14h
CDC eyes narrower COVID-19 vaccine guidance ahead of 2025–2026 season
The CDC’s vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including the COVID-19 vaccine for 2025-2026.  Read More ...